• Genetics and Genomics
• Proteomics
• Drug Development
• Molecular Epidemiology
• Autoimmunity
• Type 1 Diabetes

My laboratory focuses on the development of highly integrated platforms (genomics, proteomics and drug screening) for the studies of systems biology and complex diseases using both animal models and human populations. Our goal is to understand the mechanism of diseases and to develop novel prediction and treatment strategies for a variety of diseases including type1 diabetes and cancer.

1. Microarray technologies for global gene expression
2. Mass spectrometry analyses for proteins
3. High throughput screening of chemical compound library
4. Congenic and knockout animal models for autoimmune diseases
5. Neonatal screening for type 1 diabetes

1. Opportunity to build a first class center for genomic research at MCG.
2. Opportunities to develop integrated research initiatives with multiple research institutions in Georgia.